Skip to main content
. 2021 Jan 30;214:113233. doi: 10.1016/j.ejmech.2021.113233

Table 1.

Antiviral and anti-tumor nucleoside drugs currently on the market.

Bioactivities Drug names
Antiviral Broad-spectrum antiviral drug Ribavirin
Anti-HIV Zidovudine, Didanosine, Zalcitabine, Stavudine, Lamivudine, Abacavir, Tenofovir, Emtricitabine
Anti-HBV Lamivudine, Telbivudine, Adefovir dipivoxil, Emtricitabine, Entecavir, Ttenofovir disoproxil, Clevudine
Anti-HCV Sofosbuvir
Anti-herpes virus Idoxuridine, Trifluorothymidine, Brivudine, Acyclovir, Valacyclovir, Penciclovir, Famciclovir, Ganciclovir, Formimivir, Cidofovir
Anti-COVID-19 Remdesivir
Anti-tumor 6-Mercaptopurine, 6-Mercaptoguanine, Fludarabine, Clofarabine, Cladribine, Adenine arabinoside, Nelarabine, Cytarabine, Decitabine, Enocitabine, Troxacitabine, 5-FU, Gemcitabine, Zalcitabine, Capecitabine, CNDAC